**Question:** Which of the following antiepileptic drugs can be used to treat neonatal jaundice?

A. Phenobarbitone
B. Valproic acid
C. Carbamazepine
D. Levetiracetam

**Core Concept:** Neonatal jaundice is a condition characterized by the excessive accumulation of bilirubin in the bloodstream, leading to yellow discoloration of the skin and internal organs. Treatment options include phototherapy and, in some cases, pharmacological interventions.

**Why the Correct Answer is Right:** D-Levetiracetam is an antiepileptic drug primarily used to manage epilepsy in adults and children. In neonates, levetiracetam can be considered for treating severe neonatal jaundice when phototherapy is insufficient or contraindicated. Its mechanism of action involves binding to specific neuronal proteins, inhibiting the release of excitatory amino acids, and reducing neuronal excitability.

**Why Each Wrong Option is Incorrect:**

A. Phenobarbitone: Though phenobarbitone is an effective antiepileptic drug, it is not specifically used for neonatal jaundice treatment. Its role lies mainly in managing epilepsy, status epilepticus, and convulsions.

B. Valproic acid: Valproic acid is primarily used for seizure management, not neonatal jaundice treatment. Its off-label use in neonates may cause severe side effects like hepatotoxicity, encephalopathy, and ketoacidosis.

C. Carbamazepine: Carbamazepine is commonly used as an antiepileptic drug but is not typically recommended for neonatal jaundice treatment. It has potential risks, including hypotension, hypoglycemia, and thrombocytopenia.

**Clinical Pearl:** Neonatal jaundice management typically involves supportive care, such as phototherapy, in most cases. In rare instances, when phototherapy fails or is contraindicated, levetiracetam can be considered as a last resort, considering its potential benefits and risks. Always involve a pediatrician or neonatologist in managing severe neonatal jaundice cases.